Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prostate Cancer 2020: "The Times They Are a'Changing".

Literature DB >> 32663466

Prostate Cancer 2020: "The Times They Are a'Changing".

Abstract

Prostate cancer (PC) care is rapidly evolving, with improved treatment options and outcomes. Trials recently published in the New England Journal of Medicine report on an oral lutenizing-hormone-releasing hormone antagonist with superior endocrine and tolerability profiles and positive outcomes for non-metastatic PC with androgen receptor antagonists, respectively.

Entities: Disease Gene

Year: 2020 PMID： 32663466 DOI： 10.1016/j.ccell.2020.06.008

Source DB: PubMed Journal: Cancer Cell ISSN： 1535-6108 Impact factor: 31.743

Keyword Cloud
Cited

8 in total

1. Head-to-head comparison of [⁶⁸ Ga]Ga-P16-093 and [⁶⁸ Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients.

Authors: Guochang Wang; Haiyan Hong; Jie Zang; Qingxing Liu; Yuanyuan Jiang; Xinrong Fan; Zhaohui Zhu; Lin Zhu; Hank F Kung
Journal: Eur J Nucl Med Mol Imaging Date: 2021-09-23 Impact factor: 9.236

Review 2. The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.

Authors: Monyse de Nóbrega; Mariana Bisarro Dos Reis; Érica Romão Pereira; Marilesia Ferreira de Souza; Ilce Mara de Syllos Cólus
Journal: J Cancer Res Clin Oncol Date: 2022-08-04 Impact factor: 4.322

Review 3. Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.

Authors: Qing Wu; Wei Qian; Xiaoli Sun; Shaojie Jiang
Journal: J Hematol Oncol Date: 2022-10-08 Impact factor: 23.168

Prostate Cancer 2020: "The Times They Are a'Changing".

1. Head-to-head comparison of [⁶⁸ Ga]Ga-P16-093 and [⁶⁸ Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients.

Review 2. The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.

Review 3. Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.

4. Sex steroid modulation of macrophages within the prostate tumor microenvironment.

5. The Primacy of High B-Value 3T-DWI Radiomics in the Prediction of Clinically Significant Prostate Cancer.

6. Emerging landscape of circHIPK3 and its role in cancer and other diseases (Review).

Review 7. Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers.

Review 8. Lin28 Regulates Cancer Cell Stemness for Tumour Progression.

Prostate Cancer 2020: "The Times They Are a'Changing".

1. Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients.

Review 2. The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.

Review 3. Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.

4. Sex steroid modulation of macrophages within the prostate tumor microenvironment.

5. The Primacy of High B-Value 3T-DWI Radiomics in the Prediction of Clinically Significant Prostate Cancer.

6. Emerging landscape of circHIPK3 and its role in cancer and other diseases (Review).

Review 7. Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers.

Review 8. Lin28 Regulates Cancer Cell Stemness for Tumour Progression.

1. Head-to-head comparison of [⁶⁸ Ga]Ga-P16-093 and [⁶⁸ Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients.